story of the week
Prognosis of Patients With Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy Based on Tumor Subtype and Germline BRCA Mutation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
Breast Cancer Res Treat 2022 Sep 07;[EPub Ahead of Print], SY Park, KJ Suh, DW Lee, HS Ryu, M Kim, SH Kim, KH Lee, TY Kim, JH Kim, IA Park, SA ImFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.